Newly Diagnosed Cases of Major Hemoglobinopathies (2016-2021) in Duhok: How Effective is The Premarital Preventive Program?

Israa Khaleel  Isamil; Nasir  Al-Allawi

doi:10.56056/amj.2025.353

Authors

Israa Khaleel Isamil MBChB; Senior House Officer, Department of Hematology, Azadi Teaching Hospital, Duhok, Kurdistan region, Iraq
Nasir Al-Allawi MBChB, MSc, PhD, FRCPath; Professor of Hematology, College of Medicine, University of Duhok, Duhok, Iraq

DOI:

https://doi.org/10.56056/amj.2025.353

Keywords:

Hemoglobinopathies, Iraq, Premarital screening program

Abstract

Background and objectives: The hemoglobinopathy preventive program in Duhok has been implemented since 2008. We aimed to assess the effectiveness of the program through its ability to reduce the number of newly diagnosed cases.

Methods: In this retrospective descriptive study, we reviewed newly diagnosed major hemoglobinopathy patients in the period between Jan. 2016 and Dec. 2021 in Duhok, Iraq. Parents of patients were interviewed regarding premarital screening, counseling, and prenatal diagnosis. For those missed by former screening, further testing was performed.

Results: A total of 160 newly diagnosed major hemoglobinopathies over the study timeframe were recorded, with a modest decline of these cases from 35 in 2016 to 21 in 2021. Of the 160 cases, 150 were available for assessment. The parents of 50 patients (33.3%) did premarital screening: 43 were identified to be at risk, but seven were missed. The parents of 100 patients (66.7%), however, did not do premarital screening. The most frequent reasons for not seeking prenatal diagnosis being unaware of availability/being too expensive (57.5%), or for religious/cultural beliefs (35.0%).

Conclusions: The modest reduction in the numbers of newly diagnosed major hemoglobinopathies, should be viewed in context, but is below the ultimate aims of the program. There is a need to tackle the challenges posed by couples marrying despite risk, or before the program was initiated, as well as the availability, religious, and legal aspects of prenatal diagnosis and termination of affected pregnancies to ensure a more favorable outcome of the program.

Downloads

Download data is not yet available.

References

- Al-Allawi N, Al Allawi S, Jalal SD. Genetic epidemiology of hemoglobinopathies among Iraqi Kurds. J Community Genet. 2021;12(1):5-14.

- Al-Allawi NA, Al-Dousky AA. Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme. East Mediterr Health J. 2010;16(4):381-385.

- Jalal SD, Al-Allawi NA, Faraj AH, Ahmed NH. Prevalence of haemoglobinopathies in Sulaimani–Iraq. Duhok Med J 2008; 2: 71–97.

- Al-Allawi N. The preventive program for haemoglobinopathies in Duhok: an option or a necessity. Duhok Med J. 2008; 2:1–4.

- Al-Allawi NA, Jalal SD, Ahmed NH, Faraj AH, Shalli A, Hamamy H. The first five years of a preventive programme for haemoglobinopathies in Northeastern Iraq. J Med Screen. 2013; 20(4):171-176.

- Al-Allawi NA, Al-Doski AA, Markous RS, Mohamad Amin KA, Eissa AA, Badi AI, et al. Premarital screening for hemoglobinopathies: experience of a single center in Kurdistan, Iraq. Public Health Genomics. 2015; 18(2): 97-103.

- Saffi M, Howard N. Exploring the Effectiveness of Mandatory Premarital Screening and Genetic Counselling Programmes for -Thalassaemia in the Middle East: A Scoping Review. Public Health Genomics. 2015; 18(4): 193-203.

- Giambona A, Damiani G, Vinciguerra M, Jakil C, Cannata M, Cassarà F, et al. Incidence of haemoglobinopathies in Sicily: the impact of screening and prenatal diagnosis. Int J Clin Pract. 2015; 69(10):1129-1138.

- Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013; 3(2): a011775.

- Bozkurt G. Results from the north cyprus thalassemia prevention program. Hemoglobin. 2007;31(2):257-264.

- Zeinalian M, Nobari RF, Moafi A, Salehi M, Hashemzadeh-Chaleshtori M. Two decades of pre-marital screening for beta-thalassemia in central Iran. J Community Genet. 2013; 4(4): 517-522.

- Karimi M, Jamalian N, Yarmohammadi H, Askarnejad A, Afrasiabi A, Hashemi A. Premarital screening for beta-thalassaemia in Southern Iran: options for improving the programme. J Med Screen. 2007;14(2):62-66.

- Miri-Moghaddam E, Naderi M, Izadi S, Mashhadi M. Causes of new cases of major thalassemia in Sistan and Balouchistan province in South-East of Iran. Iran J Public Health. 2012;41(11):67-71.

- Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th edition, Oxford, Blackwell Scientific Publications, 2001.

- Galanello R, Eleftheriou A, Trager-Synodinos J, Old J, Petrou M, Angastiniotis M. Prevention of Thalassemia and other haemoglobin disorders. Volume 1. Thalassemia International Federation Publications, Nicosia, 2003.

- Bain BJ, Wild BJ, Stephens AD, Phelan LA. Variant haemoglobins: A guide to identification, Wiley-Blackwell Publications, Chichester, 2010.

- Rosnah B, Nani Shahida NS, Mohd Nazri MH, Marini R, Noor Haslina MN, Shafini, MY, et al. The diagnosis of beta thalassemia with borderline HbA2 level among Kelantan population. J Blood Disord Transfus. 2017; 8(5): 1000396.

- Colaco S, Colah R, Nadkarni A. Significance of borderline HbA2 in thalassemia carrier screening. Scientific Reports 2022; 12: 5414.

- Moafi A, Vallian R, Vallian S, Rahgozar S, Torfenajad M, Moafi H. The pros and cons of the fourth revision of thalassaemia screening programme in Iran. J Med Screen. 2017;24(1):1-5.

- Suhaimi SA, Zulkipli IN, Ghani H, Abdul-Hamid MR. Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review. Front Pediatr. 2022; 10: 1015769.

- Bain BJ, Daniel Y, Henthorn J, de la Salle B, Hogan A, Roy NBA, et al. Significant haemoglobinopathies: A guideline for screening and diagnosis. Br J Haematol. 2023; 201(6): 1047-1065.

- Sediq RA, Sulaiman SA, Al-Allawi N. Attitude and Knowledge of Couples Towards the Premarital Hemoglobinopathy Screening Program in Duhok –Iraq. AMJ. 2023; 10(2): in Press.